Brainsway Ltd. Sponsored ADR

BWAY Healthcare Medical Devices

Brainsway Ltd. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $52.2 million, up 27.3% from fiscal 2024. In the quarter to June 2026, revenue grew 35.4%, EPS grew 40.0% and free cash flow fell 51.7%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.

11.41 0.41 −3.47%
Market cap
$475.8M
P/E
24.8×
Fwd P/E
0.0×
Dividend yield
—
F-score
6/9
Altman Z
2.82
Beneish M
−2.45
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

31.42 26.42 31.64 33.72
P/S ratio
6.01 3.46 4.51 4.95
P/FCF ratio
16.09 11.93 21.90 51.89
P/Operating CF
212.98 (139.98) 216.58 47.62
P/B ratio
4.21 2.47 3.35 3.79
EV/Sales
4.61 2.19 3.49 3.95
EV/EBITDA
47.82 19.48 26.69 25.97
EV/FCF
12.34 7.54 16.96 41.42
Current Ratio
3.19 3.73 3.34 3.59
Net Debt/EBITDA
(43.32) (30.59) (24.30) (22.39)
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
3.18% 3.79% 3.16% 2.97%
Free Cash Flow Yield
6.21% 8.38% 4.57% 1.93%
Free Cash Flow per Share
0.02 (0.03) 0.02 0.28
Book value per Share
1.79 3.85 3.97 4.09
Free Cash Flow
0.59 (0.62) 0.40 5.42
EV/EBIT
79.73 26.42 34.15 31.68
Other line items

Show all line items

Columns are period end dates